{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:04:01Z","timestamp":1775001841476,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:00:00Z","timestamp":1329782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2012.3","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T16:49:19Z","timestamp":1329842959000},"page":"e82-e82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients"],"prefix":"10.1038","volume":"2","author":[{"given":"E","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P C","family":"Guest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Bogerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,21]]},"reference":[{"key":"BFtp20123_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0920-9964(99)00084-5","volume":"49","author":"PF Buckley","year":"2001","unstructured":"Buckley PF, Friedman L, Krowinski AC, Eaton Y, Tronetti M, Miller DD . Clinical and biochemical correlates of \u2033high-dose\u2033 clozapine therapy for treatment-refractory schizophrenia. Schizophr Res 2001; 49: 225\u2013227.","journal-title":"Schizophr Res"},{"key":"BFtp20123_CR2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","volume":"158","author":"M Chakos","year":"2001","unstructured":"Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B . Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry 2001; 158: 518\u2013526.","journal-title":"Am J Psychiatry"},{"key":"BFtp20123_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1017\/S1461145710000866","volume":"13","author":"EH Wong","year":"2010","unstructured":"Wong EH, Yocca F, Smith MA, Lee CM . Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters\u2019 perspective. Int J Neuropsychopharmacol 2010; 13: 1269\u20131284.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp20123_CR4","first-page":"135","volume":"7","author":"ME McIlwain","year":"2011","unstructured":"McIlwain ME, Harrison J, Wheeler AJ, Russell BR . Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatr Dis Treat 2011; 7: 135\u2013149.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFtp20123_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.neuropharm.2011.02.017","volume":"61","author":"BA Samuels","year":"2011","unstructured":"Samuels BA, Leonardo ED, Gadient R, Williams A, Zhou J, David DJ et al. Modeling treatment-resistant depression. Neuropharmacology 2011; 61: 408\u2013413.","journal-title":"Neuropharmacology"},{"key":"BFtp20123_CR6","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1158\/1078-0432.CCR-10-2234","volume":"17","author":"LH Butterfield","year":"2011","unstructured":"Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, Hakansson L, Janetzki S et al. Recommendations from the iSBTc-SITC\/FDA\/NCI Workshop on Immunotherapy Biomarkers. Clin Cancer Res 2011; 17: 3064\u20133076.","journal-title":"Clin Cancer Res"},{"key":"BFtp20123_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF03257193","volume":"15","author":"J Hoggatt","year":"2011","unstructured":"Hoggatt J . Personalized medicine--trends in molecular diagnostics: exponential growth expected in the next ten years. Mol Diagn Ther 2011; 15: 53\u201355.","journal-title":"Mol Diagn Ther"},{"key":"BFtp20123_CR8","doi-asserted-by":"crossref","unstructured":"Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM et al. Identification of a biological signature for schizophrenia in serum. Mol Psychiatry 2011; e-pub ahead of print.","DOI":"10.1038\/mp.2011.42"},{"key":"BFtp20123_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4137\/BMI.S4877","volume":"5","author":"E Schwarz","year":"2010","unstructured":"Schwarz E, Izmailov R, Spain M, Barnes A, Mapes JP, Guest PC et al. Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomark Insights 2010; 5: 39\u201347.","journal-title":"Biomark Insights"},{"key":"BFtp20123_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0140-6736(03)12122-8","volume":"361","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt PM, Reitsma JB . The STARD initiative. Lancet 2003; 361: 71.","journal-title":"Lancet"},{"key":"BFtp20123_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 1995; 57: 289\u2013300.","journal-title":"J Roy Statist Soc Ser B"},{"key":"BFtp20123_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","volume":"34","author":"AG Barnett","year":"2005","unstructured":"Barnett AG, van der Pols JC, Dobson AJ . Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005; 34: 215\u2013220.","journal-title":"Int J Epidemiol"},{"key":"BFtp20123_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L . Random forests. Machine Learning 2001; 45: 5\u201332.","journal-title":"Machine Learning"},{"key":"BFtp20123_CR14","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1136\/bmj.308.6942.1499","volume":"308","author":"JM Bland","year":"1994","unstructured":"Bland JM, Altman DG . Regression towards the mean. BMJ 1994; 308: 1499.","journal-title":"BMJ"},{"issue":"Suppl 27","key":"BFtp20123_CR15","first-page":"27","volume":"62","author":"JM Meyer","year":"2001","unstructured":"Meyer JM . Effects of atypical antipsychotics on weight and serum lipid levels. J Clin Psychiatry 2001; 62 (Suppl 27): 27\u201334; discussion 40\u201321.","journal-title":"J Clin Psychiatry"},{"key":"BFtp20123_CR16","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1021\/ac051916x","volume":"78","author":"Y Yang","year":"2006","unstructured":"Yang Y, Wan C, Li H, Zhu H, La Y, Xi Z et al. Altered levels of acute phase proteins in the plasma of patients with schizophrenia. Anal Chem 2006; 78: 3571\u20133576.","journal-title":"Anal Chem"},{"key":"BFtp20123_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/archpsyc.1976.01770030003001","volume":"33","author":"HY Meltzer","year":"1976","unstructured":"Meltzer HY, Fang VS . The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry 1976; 33: 279\u2013286.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp20123_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.psyneuen.2010.12.018","volume":"36","author":"PC Guest","year":"2011","unstructured":"Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M et al. Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology 2011; 36: 1092\u20131096.","journal-title":"Psychoneuroendocrinology"},{"key":"BFtp20123_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01317.x","volume":"119","author":"JM Meyer","year":"2009","unstructured":"Meyer JM, Stahl SM . The metabolic syndrome and schizophrenia. Acta Psychiatr Scand 2009; 119: 4\u201314.","journal-title":"Acta Psychiatr Scand"},{"key":"BFtp20123_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0893-133X(00)00201-3","volume":"24","author":"HY Meltzer","year":"2001","unstructured":"Meltzer HY, Lee MA, Jayathilake K . The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia. Neuropsychopharmacology 2001; 24: 278\u2013290.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp20123_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00004714-200206000-00003","volume":"22","author":"P Czobor","year":"2002","unstructured":"Czobor P, Volavka J, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J et al. Antipsychotic-induced weight gain and therapeutic response: a differential association. J Clin Psychopharmacol 2002; 22: 244\u2013251.","journal-title":"J Clin Psychopharmacol"},{"key":"BFtp20123_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0920-9964(01)00326-7","volume":"59","author":"HY Meltzer","year":"2003","unstructured":"Meltzer HY, Perry E, Jayathilake K . Clozapine-induced weight gain predicts improvement in psychopathology. Schizophr Res 2003; 59: 19\u201327.","journal-title":"Schizophr Res"},{"issue":"Suppl 3","key":"BFtp20123_CR23","first-page":"16","volume":"23","author":"J Girard","year":"1997","unstructured":"Girard J . Is leptin the link between obesity and insulin resistance? Diabetes Metab 1997; 23 (Suppl 3): 16\u201324.","journal-title":"Diabetes Metab"},{"key":"BFtp20123_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1536\/ihj.52.17","volume":"52","author":"Y Kajikawa","year":"2010","unstructured":"Kajikawa Y, Ikeda M, Takemoto S, Tomoda J, Ohmaru N, Kusachi S . Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. Int Heart J 2010; 52: 17\u201322.","journal-title":"Int Heart J"},{"key":"BFtp20123_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3346\/jkms.2008.23.4.685","volume":"23","author":"BJ Kim","year":"2008","unstructured":"Kim BJ, Sohn JW, Park CS, Hahn GH, Koo J, Noh YD et al. Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine. J Korean Med Sci 2008; 23: 685\u2013690.","journal-title":"J Korean Med Sci"},{"key":"BFtp20123_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1192\/bjp.184.1.58","volume":"184","author":"ZJ Zhang","year":"2004","unstructured":"Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP . Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry 2004; 184: 58\u201362.","journal-title":"Br J Psychiatry"},{"key":"BFtp20123_CR27","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","volume":"32","author":"T Sato","year":"2011","unstructured":"Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T . Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 2011; 32: 1626\u20131633.","journal-title":"Neurobiol Aging"},{"key":"BFtp20123_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neulet.2006.11.019","volume":"412","author":"N Pannacciulli","year":"2007","unstructured":"Pannacciulli N, Le DS, Chen K, Reiman EM, Krakoff J . Relationships between plasma leptin concentrations and human brain structure: a voxel-based morphometric study. Neurosci Lett 2007; 412: 248\u2013253.","journal-title":"Neurosci Lett"},{"key":"BFtp20123_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/mp.2009.81","volume":"15","author":"PC Guest","year":"2010","unstructured":"Guest PC, Wang L, Harris LW, Burling K, Levin Y, Ernst A et al. Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naive schizophrenia patients. Mol Psychiatry 2010; 15: 118\u2013119.","journal-title":"Mol Psychiatry"},{"key":"BFtp20123_CR30","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4088\/JCP.v65n1007","volume":"65","author":"B Arranz","year":"2004","unstructured":"Arranz B, Rosel P, Ramirez N, Duenas R, Fernandez P, Sanchez JM et al. Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients. J Clin Psychiatry 2004; 65: 1335\u20131342.","journal-title":"J Clin Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp20123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp20123","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp20123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T04:58:00Z","timestamp":1713589080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp20123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,21]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2]]}},"alternative-id":["BFtp20123"],"URL":"https:\/\/doi.org\/10.1038\/tp.2012.3","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,21]]},"assertion":[{"value":"16 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}